Zevin Asset Management LLC boosted its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 5.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 139,302 shares of the company's stock after buying an additional 7,793 shares during the quarter. Colgate-Palmolive makes up approximately 1.9% of Zevin Asset Management LLC's investment portfolio, making the stock its 21st largest position. Zevin Asset Management LLC's holdings in Colgate-Palmolive were worth $12,664,000 at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in CL. Commonwealth Financial Services LLC raised its stake in Colgate-Palmolive by 4.5% in the 4th quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company's stock valued at $247,000 after acquiring an additional 118 shares during the period. D Orazio & Associates Inc. increased its position in shares of Colgate-Palmolive by 4.2% during the fourth quarter. D Orazio & Associates Inc. now owns 2,982 shares of the company's stock valued at $271,000 after buying an additional 120 shares during the period. Lantz Financial LLC increased its position in shares of Colgate-Palmolive by 0.6% during the fourth quarter. Lantz Financial LLC now owns 20,140 shares of the company's stock valued at $1,831,000 after buying an additional 122 shares during the period. Horizon Kinetics Asset Management LLC increased its position in shares of Colgate-Palmolive by 4.2% during the third quarter. Horizon Kinetics Asset Management LLC now owns 3,102 shares of the company's stock valued at $322,000 after buying an additional 124 shares during the period. Finally, Pine Haven Investment Counsel Inc increased its position in shares of Colgate-Palmolive by 1.0% during the fourth quarter. Pine Haven Investment Counsel Inc now owns 13,006 shares of the company's stock valued at $1,182,000 after buying an additional 130 shares during the period. Institutional investors own 80.41% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts have recently weighed in on CL shares. Royal Bank of Canada reiterated a "sector perform" rating and set a $101.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. TD Cowen decreased their price target on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a research report on Wednesday, January 8th. Raymond James reiterated an "outperform" rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. UBS Group decreased their price target on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating on the stock in a research report on Monday, February 3rd. Finally, Stifel Nicolaus cut their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have given a buy rating to the company's stock. Based on data from MarketBeat.com, Colgate-Palmolive has a consensus rating of "Hold" and an average target price of $101.72.
Read Our Latest Stock Report on CL
Colgate-Palmolive Trading Up 1.1 %
Shares of NYSE:CL traded up $0.95 during trading on Wednesday, reaching $90.44. 8,242,135 shares of the company traded hands, compared to its average volume of 4,191,857. The firm has a market capitalization of $73.39 billion, a price-to-earnings ratio of 25.69, a P/E/G ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The business's fifty day moving average is $89.13 and its 200-day moving average is $94.44.
Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter last year, the firm earned $0.87 earnings per share. As a group, analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.
About Colgate-Palmolive
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.